12/12
04:46 pm
envb
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
Low
Report
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
12/11
01:43 pm
envb
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
High
Report
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds
12/9
08:00 am
envb
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
Medium
Report
Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates
12/4
08:00 am
envb
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
Medium
Report
Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026”
11/26
08:00 am
envb
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
Low
Report
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
11/14
04:54 pm
envb
Enveric Biosciences GAAP EPS of -$10.81 [Seeking Alpha]
Medium
Report
Enveric Biosciences GAAP EPS of -$10.81 [Seeking Alpha]
11/14
04:26 pm
envb
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results [Yahoo! Finance]
Medium
Report
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results [Yahoo! Finance]
11/14
04:05 pm
envb
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
Medium
Report
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
10/23
08:00 am
envb
Enveric Biosciences Announces Reverse Stock Split
Medium
Report
Enveric Biosciences Announces Reverse Stock Split
10/16
08:30 am
envb
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
High
Report
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
10/15
08:00 am
envb
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
High
Report
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
10/14
08:11 pm
envb
Enveric Biosciences to Explore Digital Asset Treasury Opportunities [Yahoo! Finance]
High
Report
Enveric Biosciences to Explore Digital Asset Treasury Opportunities [Yahoo! Finance]
10/14
09:05 am
envb
Enveric Biosciences to explore digital asset treasury opportunities [Seeking Alpha]
Medium
Report
Enveric Biosciences to explore digital asset treasury opportunities [Seeking Alpha]
10/14
09:00 am
envb
Enveric Biosciences to Explore Digital Asset Treasury Opportunities
Medium
Report
Enveric Biosciences to Explore Digital Asset Treasury Opportunities
10/3
03:35 pm
envb
Enveric Biosciences (NASDAQ:ENVB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Enveric Biosciences (NASDAQ:ENVB) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/2
08:56 am
envb
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials [Yahoo! Finance]
High
Report
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials [Yahoo! Finance]
10/2
08:45 am
envb
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials
Medium
Report
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials